Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biogen hepatitis B patents

Executive Summary

Abbott joins list of firms licensing Biogen's hepatitis B patents. Royalty-bearing license covers manufacture, use and sale of hepatitis B core antigens in diagnostic kits. Biogen estimates that its hepatitis B licensing program, which includes SmithKline licensure for its hepatitis B vaccine, could yield $ 10 mil. a year in product-driven revenues. A separate patent for hepatitis B surface antigen produced from genetically engineered yeast, which covers Merck's Recombivax HB vaccine, was granted Sept. 6 to inventors of the vaccine at the University of California ("The Pink Sheet" Sept. 12, "In Brief").

You may also be interested in...



Dr Reddy's Isolates Data Service Centers Among Preventive Actions Responding To Cyberattack

J&J Faces Fraud Claims From Merger With Surgical Robot Firm

Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.

As Pandemic Boosts Demand For Immunity Supplements, Dentovations Launches Self+ Line

based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.

UsernamePublicRestriction

Register

ID1132327

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel